When The Issuer Moves for Lead Plaintiff: Genius Group Ltd. v. Citadel Securities LLC, 2026 WL 1760342 (S.D.N.Y. June 18, 2026)

In a lead plaintiff contest involving unique circumstances, the United States District Court for the Southern District of New York rejected issuer and public company Genius Group Limited’s (“Genius”) application to serve as lead plaintiff in Genius Group Ltd. v. Citadel Securities LLC, 2026 WL 1760342 (S.D.N.Y. June 18, 2026). The securities class action lawsuit alleges that Citadel Securities LLC and Virtu Americas LLC (collectively, the “Defendants”) engaged in manipulative trading by submitting and then immediately canceling thousands of orders in Genius common stock without any genuine intent to execute them, thereby creating the appearance of supply and demand. This practice, known as “spoofing,” allegedly violated Sections 9 and 10(b) of the Securities Exchange Act of 1934 and SEC Rule 10b-5.

While motions for appointment as lead plaintiff in a securities class action are typically brought by ordinary investors who suffered harm due to a company’s and/or its officers’ alleged fraud, here, the lead plaintiff movant was the issuer and company itself, claiming harm from the alleged “spoofing” Defendants.

As the Court explained, the lead plaintiff is generally the movant that “has the largest financial interest in the relief sought by the class” and who “otherwise satisfies the requirements of Rule 23 of the Federal Rules of Civil Procedure.” 15 U.S.C. § 78u-4(a)(3)(B)(i). To satisfy Rule 23, a movant must demonstrate typicality, i.e., that its “claim[s] arise[] from the same course of events” and that it will “make[] similar legal arguments to prove the defendant’s liability” as the absent class members. Elstein v. Netl UEPS Techs., Inc., No. 13-CV-9100 (ER), 2014 WL 3687277, at *7 (S.D.N.Y. July 23, 2014).  The movant must also demonstrate adequacy, i.e., that it “does not have interests that are antagonistic to the class…and has retained counsel that is capable and qualified to vigorously represent the interests of the class that [it] seeks to represent.” Glauser v. EVCI Ctr. Colls. Holding Corp., 236 F.R.D. 184, 189 (S.D.N.Y. 2006).

Despite claiming the largest financial interest, the Court found that Genius failed to satisfy Rule 23’s typicality requirement. Specifically, as an issuer, Genius issued shares through private transactions at contractually determined prices that diverged from market prices and therefore could not show that it traded in reliance on the market price for its common stock in the same manner as the absent class members. The Court also noted that Genius disposed of approximately 80% of its shares through atypical transactions including conversions, warrant exercises, option exercises, and merger consideration.

Although “deciding that Genius is not typical [wa]s sufficient to deny Genius’s Motion,” the Court also found that Genius failed to satisfy Rule 23’s adequacy requirement because it was subject to unique defenses. Specifically, as the issuer and the entity allegedly harmed, Genius “may have discovered the violations alleged in the Complaint well more than two years prior to filing suit,” raising a potentially case-dispositive statute of limitations defense.  The Court pointed to the Genius’s independent investigation “seemingly beginning in November 2022, and its announcement in January 2023 that it had ‘proof’ of misconduct.”

Not only did the Court deny Genius’s motion for appointment as lead plaintiff, it also declined to reopen the lead plaintiff application process and directed that the action proceed on behalf of Genius on an individual basis.